Cefdinir

Results: 11



#Item
1Acute Knee Injury Encounter Form Patient’s name: Age: 	  History of present illness

Acute Knee Injury Encounter Form Patient’s name: Age: History of present illness

Add to Reading List

Source URL: www.aafp.org

Language: English - Date: 2014-02-20 15:39:23
2Acute Otitis Media (AOM) Encounter Form Patient’s name: Age/Date of birth: 	  /

Acute Otitis Media (AOM) Encounter Form Patient’s name: Age/Date of birth: /

Add to Reading List

Source URL: www.aafp.org

Language: English - Date: 2014-02-20 15:39:23
3Acute Otitis Media (AOM) Encounter Form Patient’s name: Age/Date of birth: 	  /

Acute Otitis Media (AOM) Encounter Form Patient’s name: Age/Date of birth: /

Add to Reading List

Source URL: www.aafp.org

Language: English - Date: 2014-02-20 15:39:08
4Astellas Pharma / Cefdinir

September 10, 2007 Court Dismisses Appeal Filed by Taiyo Yakuhin Co., Ltd. of Patent Infringement Suit on Oral Cephalosporin Antibiotic Cefzon® Capsule Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; Presiden

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-18 20:56:04
5December 27, 2007 Astellas Won the Patent Infringement Suit on Oral Cephalosporin Antibiotic Cefzon® Capsule Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) today announc

December 27, 2007 Astellas Won the Patent Infringement Suit on Oral Cephalosporin Antibiotic Cefzon® Capsule Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) today announc

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-18 20:25:02
6March 5, 2008  Astellas Reaches Settlement Agreement with Taiyo on the Oral Cephalosporin Antibiotic Cefzon® Litigations  Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori)

March 5, 2008 Astellas Reaches Settlement Agreement with Taiyo on the Oral Cephalosporin Antibiotic Cefzon® Litigations Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori)

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-18 00:23:05
7August 9, 2007 Astellas Filed a Lawsuit against Taiyo Yakuhin Co., Ltd. Claiming Damages on the Oral Cephalosporin Antibiotic Cefzon® Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafum

August 9, 2007 Astellas Filed a Lawsuit against Taiyo Yakuhin Co., Ltd. Claiming Damages on the Oral Cephalosporin Antibiotic Cefzon® Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafum

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2008-09-18 21:15:37
8Interim Revision Announcement Official September 1, 2014 Cefdinir 1 Acceptance criteria: 90.0%–110.0%

Interim Revision Announcement Official September 1, 2014 Cefdinir 1 Acceptance criteria: 90.0%–110.0%

Add to Reading List

Source URL: www.usp.org

Language: English - Date: 2014-07-16 15:29:35
9RECOMMENDED ANTIMICROBIAL TREATMENT FOR COMMON ILLNESSES: CHILDREN  CHILDREN OTITIS MEDIA TREAT <2y OR >2y IF SEVERE SX

RECOMMENDED ANTIMICROBIAL TREATMENT FOR COMMON ILLNESSES: CHILDREN CHILDREN OTITIS MEDIA TREAT <2y OR >2y IF SEVERE SX

Add to Reading List

Source URL: www.maine.gov

Language: English - Date: 2014-04-22 13:18:23
10Comments were received for the following, when they were proposed in the Pharmacopeial Forum: Monograph/Sections: Cefdinir Capsules/Assay Expert Committee: Monographs—Small Molecules 1

Comments were received for the following, when they were proposed in the Pharmacopeial Forum: Monograph/Sections: Cefdinir Capsules/Assay Expert Committee: Monographs—Small Molecules 1

Add to Reading List

Source URL: www.usp.org

Language: English - Date: 2014-07-28 11:26:55